Developing a normative database for retinal perfusion using optical coherence tomography angiography

March 10, 2026
Share on

AUTHORS

Bingyao Tan, Yin Ci Sim, Jacqueline Chua, Dheo Yusufi, Damon Wong, Ai Ping Yow, Calvin Chin, Anna C S Tan, Chelvin C A Sng, Rupesh Agrawal, Lekha Gopal, Ralene Sim, Gavin Tan, Ecosse Lamoureux, Leopold Schmetterer

Biomed Opt Express. 2021 Jun 14;12(7):4032-4045. doi: 10.1364/BOE.423469. eCollection 2021 Jul 1.

ABSTRACT

Visualizing and characterizing microvascular abnormalities with optical coherence tomography angiography (OCTA) has deepened our understanding of ocular diseases, such as glaucoma, diabetic retinopathy, and age-related macular degeneration. Two types of microvascular defects can be detected by OCTA: focal decrease because of localized absence and collapse of retinal capillaries, which is referred to as the non-perfusion area in OCTA, and diffuse perfusion decrease usually detected by comparing with healthy case-control groups. Wider OCTA allows for insights into peripheral retinal vascularity, but the heterogeneous perfusion distribution from the macula, parapapillary area to periphery hurdles the quantitative assessment. A normative database for OCTA could estimate how much individual’s data deviate from the normal range, and where the deviations locate. Here, we acquired OCTA images using a swept-source OCT system and a 12×12 mm protocol in healthy subjects. We automatically segmented the large blood vessels with U-Net, corrected for anatomical factors such as the relative position of fovea and disc, and segmented the capillaries by a moving window scheme. A total of 195 eyes were included and divided into 4 age groups: < 30 (n=24) years old, 30-49 (n=28) years old, 50-69 (n=109) years old and >69 (n=34) years old. This provides an age-dependent normative database for characterizing retinal perfusion abnormalities in 12×12 mm OCTA images. The usefulness of the normative database was tested on two pathological groups: one with diabetic retinopathy; the other with glaucoma.

PMID:34457397 | PMC:PMC8367249 | DOI:10.1364/BOE.423469

View in PubMed